A Gene Sequencing Pioneer Battles Over What It Can Buy
Is Illumina, a gene-sequencing powerhouse, trying to speed innovation in the field of cancer blood tests or thwart it with an acquisition? https://nyti.ms/3BcrnOq
In a rare in-depth interview, this billionaire man of mystery, the head of Palantir Technologies, talks about war, A.I. and America’s future. https://nyti.ms/3WOsRK7
The digital media company, which will merge with a publicly listed shell company in what is known as a SPAC deal, also lined up about $150 million in debt financing. https://nyti.ms/2SXcq1k
